Abstract
Objective
3D late gadolinium enhancement (LGE) imaging is a promising non-invasive technique for the assessment of atrial fibrosis. However, current techniques result in prolonged and unpredictable scan times and high rates of non-diagnostic images. The purpose of this study was to compare the performance of a recently proposed accelerated respiratory motion-compensated 3D water/fat LGE technique with conventional 3D LGE for atrial wall imaging.
Materials and methods
18 patients (age: 55.7±17.1 years) with atrial fibrillation underwent conventional diaphragmatic navigator gated inversion recovery (IR)-prepared 3D LGE (dNAV) and proposed image-navigator motion-corrected water/fat IR-prepared 3D LGE (iNAV) imaging. Images were assessed for image quality and presence of fibrosis by three expert observers. The scan time for both techniques was recorded.
Results
Image quality scores were improved with the proposed compared to the conventional method (iNAV: 3.1 ± 1.0 vs. dNAV: 2.6 ± 1.0, p = 0.0012, with 1: Non-diagnostic to 4: Full diagnostic). Furthermore, scan time for the proposed method was significantly shorter with a 59% reduction is scan time (4.5 ± 1.2 min vs. 10.9 ± 3.9 min, p < 0.0001). The images acquired with the proposed method were deemed as inconclusive less frequently than the conventional images (expert 1/expert 2: 4/7 dNAV and 2/4 iNAV images inconclusive).
Discussion
The motion-compensated water/fat LGE method enables atrial wall imaging with diagnostic quality comparable to the current conventional approach with a significantly shorter scan of about 5 min.
Similar content being viewed by others
Explore related subjects
Find the latest articles, discoveries, and news in related topics.Avoid common mistakes on your manuscript.
Introduction
Late gadolinium enhanced (LGE) cardiac magnetic resonance (MR) imaging is a promising non-invasive tool for the comprehensive assessment of atrial morphology and fibrosis in patients with atrial fibrillation [1,2,3]. Several studies have demonstrated that the presence of fibrosis detected by LGE in the atrial wall can predict clinical outcome in patients before atrial ablation and can therefore be used for patient management and therapy planning [2, 4,5,6]. Furthermore, LGE cardiac MR has been used for the quantification of post-ablation scar, including assessment of therapy delivery and potential repeat ablation [1, 7,8,9].
Most atrial LGE imaging protocols are currently based on free-breathing diaphragmatic navigator-gated (dNAV) inversion recovery (IR)-prepared 3D gradient echo sequences, which enable the acquisition of images with sufficient spatial resolution (~ 1.3 mm in plane, 3-4 mm slice thickness) and volumetric coverage for an accurate depiction of the thin atrial wall. Data are typically acquired using a subject-specific inversion time (TI) which nulls the signal arising from the healthy myocardium, starting ~ 15–25 min after injection of a Gadolinium-based contrast agent, which allows for washout of the contrast agent in the blood and therefore improves fibrosis-to-blood pool contrast.
Although these sequences can produce diagnostic quality images in subjects with regular breathing patterns, low respiratory efficiency in subjects with irregular breathing often lead to poor image quality, due to residual motion artefacts and/or signal variations arising from heart rate variability and contrast agent washout during long scans [10, 11]. In addition, the use of dNAVs for respiratory motion compensation may result in inflow artefacts that are usually observed as a high signal intensity in the pulmonary veins, which can obscure the detection of fibrosis in that region [12]. Finally, while gadolinium dose and imaging timing protocols have been optimized to maximize the contrast between atrial LGE and atrial blood pool while nulling signal arising from healthy atrial wall, prolonged and unpredictable acquisition times of up to 15 min result in further image quality degradation due to gadolinium washout during the scan. Overall, an average ~ 23% of atrial LGE scans are reported as non-diagnostic in several studies (range 13.5–40.6% [2, 4, 5, 7, 10, 13, 14]), which in addition to the time-consuming protocol required for atrial wall LGE imaging has hindered its wide adoption in the clinical routine.
Some technical developments have focused on reducing the inflow artefact in the pulmonary veins, produced by the navigator restore pulse that is performed immediately after the IR pulse to restore liver signal, by either replacing the dNAV with an external device, such as abdominal bellows, for respiratory gating [12], or by modifying delays between preparation pulses in the acquisition sequence [15, 16]. Although by using external devices the inflow artefact is completely removed, these devices only measure the respiratory-induced motion of the heart indirectly. Indeed, the relationship between the motion of the heart and the bellows signal is non-linear, hindering their use for advanced motion compensation techniques that require quantitative motion signals [17]. Furthermore, water/fat LGE imaging has been shown to produce atrial LGE images with a more homogeneous blood pool signal compared to conventional fat saturation, while simultaneously reducing inflow artefacts [18]. However, all of these approaches use a conventional prospective respiratory gating model for motion compensation, where data are accepted for image reconstruction only when the respiratory signal is within a narrow respiratory window (usually end-expiration), resulting in long and unpredictable scan times.
In order to reduce scan time, techniques that employ radial stack-of-stars acquisitions and respiratory-resolved image reconstruction have been recently proposed [19]. While this approach enables atrial LGE imaging with good spatial resolution (1.5 × 1.5 × 2 mm) with a shorter and predictable scan time of about 6 min, the reconstruction algorithm requires over 60 min of processing time, which is impractical for wide adoption in the clinical routine.
Recently, a novel 3D water/fat sequence that enables free-breathing LGE imaging in an overall short scan time with 100% respiratory scan efficiency (no data rejection) and undersampled acquisition has been introduced [20, 21]. This sequence replaces the conventional dNAV including the navigator restore pulse with 2D image navigators (iNAVs) [22], which allow the tracking of the respiratory position of the heart on a beat-to-beat basis, so that respiratory motion estimated from the iNAVs and from the 3D data itself can be integrated into the image reconstruction algorithm to produce motion-compensated images without the need to reject any of the acquired data. The sequence uses a dual-echo readout in order to enable water/fat separation, improving fat suppression in the LGE images and producing a complementary image of the fat distribution. Furthermore, the sequence utilizes an undersampled Cartesian variable-density spiral-like trajectory [23] with favorable undersampling properties to enable further acceleration of data acquisition. This sequence has been shown to produce good image quality for the depiction of left ventricular myocardial scar, however, its performance for atrial wall imaging has not been studied so far.
The aim of this work was to study the feasibility of using this accelerated motion-compensated water/fat sequence for efficient atrial 3D LGE imaging and characterize its performance in terms of image quality and overall acquisition time compared to conventional atrial wall imaging.
Materials and methods
Patient population
Eighteen patients (age: 55.7 ± 17.1 years, 16 male, 2 female) who were referred for a clinical cardiac MR examination for atrial substrate characterization were recruited for this study between July 2019 and February 2020. Patients were eligible to participate if they were > 18 years of age and agreed to 15 min of additional MR imaging after the routine clinical imaging protocol. The cohort included patients scheduled for either first time atrial fibrillation ablation or post-ablation follow-up, and their demographics are summarized in Table 1. The study was performed in accordance with the Declaration of Helsinki and approved by the National Research Ethics Service (REC 15/NS/0030). Written informed consent was obtained from each participant according to institutional guidelines.
Accelerated motion-compensated water/fat MR imaging sequence
The accelerated motion-compensated MR image acquisition sequence consists of an ECG-triggered dual-echo 3D inversion recovery (IR)-prepared spoiled gradient echo sequence (Fig. 1 A), which enables water/fat 3D LGE imaging as described in [20]. Briefly, 3D dual-echo data are acquired with an undersampled variable-density golden-step Cartesian trajectory with spiral profile order sampling [23, 24], so that one spiral interleaf is acquired for each IR preparation pulse. Low-resolution coronal 2D iNAVs [22, 25] are acquired before the acquisition of 3D data, and are used to estimate the respiratory position of the heart in the superior-inferior (SI) and right-left (RL) directions by tracking a template located around the left atria.
The respiratory motion estimates from the 2D iNAVs are then used to produce motion-compensated 3D dual-echo datasets (Fig. 1B). Briefly, the SI motion is used to group the acquired 3D dual-echo data into a number of equally populated respiratory windows (or bins). For each bin, 3D dual-echo data are respiratory motion corrected to the center of the bin using corresponding SI & RL motion estimates. Respiratory-resolved images are then reconstructed using a soft-binning approach [26, 27] using iterative SENSE, so that 3D dual-echo images are obtained at each respiratory position. Bin-to-bin respiratory deformation fields are then estimated by performing non-rigid registration of 3D out-of-phase images [28], using the end expiratory bin as reference position. These non-rigid deformation fields are incorporated into a generalized matrix formulation for motion-corrected MR reconstruction [29], so that at the end of the image reconstruction process non-rigid motion-corrected 3D dual-echo images are obtained. Finally, these images are used as input for a 2-point Dixon algorithm to produce the final water/fat 3D LGE images [30] (Fig. 1C). The described motion-compensated reconstruction including respiratory binning and non-rigid motion correction was performed in-line on the scanner software.
Experiments
All acquisitions were performed on a 1.5 T MRI system (MAGNETOM Aera, Siemens Healthcare, Erlangen, Germany) using an 18-channel chest-coil and a 32-channel spine coil. The clinical protocol included conventional dNAV-based 3D LGE imaging, with acquisition starting 20 min after bolus injection of a double dose (0.2 mmol/kg) of a Gd-based contrast agent (Gadovist, Bayer, Berlin, Germany), with a fat-suppressed IR-prepared sequence. Relevant dNAV-based 3D LGE imaging parameters include: transverse orientation, voxel size 1.3 × 1.3 × 4 mm3, interpolated to 1.3 × 1.3 × 2 mm3 during image reconstruction, TR/TE = 3.52/1.74 ms, flip angle = 20°, bandwidth = 365 Hz/px, parallel imaging (GRAPPA with twofold undersampling and 24 reference lines), navigator gating acceptance window of size 5 mm in end-expiration.
After conventional dNAV 3D LGE imaging, data were acquired with a prototype implementation of the iNAV water/fat 3D LGE imaging sequence without additional administration of contrast agent. iNAV water/fat 3D LGE data was acquired with matching transverse orientation, voxel size and field of view, and the following parameters: TR/TE1/TE2 = 7.16/2.38/4.76 ms, flip angle = 20°, bandwidth 495 Hz/px and threefold undersampling with elliptical shutter.
For both acquisitions (i.e., dNAV and water/fat iNAV 3D LGE) a subject-specific trigger delay (275–400 ms) and acquisition window (60–110 ms) were set to coincide with atrial mid-diastole in order to minimize the effect of cardiac motion. Both of these parameters were estimated by visually inspecting a conventional breath-held 4-chamber cine acquisition. In order to enable sufficient time for signal recovery after the IR preparation pulse while maintaining a clinically feasible scan time, data was acquired every heartbeat in patients with a heart rate < 70 bpm, and every other heartbeat otherwise (identical for both dNAV and iNAV 3D LGE). The inversion time was selected to null the signal from viable myocardium by visually inspecting a breath-held 4-chamber 2D TI scout Look-Locker image acquired immediately before each 3D LGE acquisition that matched the triggering scheme of the 3D acquisition (i.e., every heartbeat for patients with heart rate < 70 bpm, and every other heartbeat otherwise).
Data analysis
Overall image quality and detectability of fibrosis in the atrial wall were analyzed for the conventional dNAV 3D LGE images and the iNAV 3D LGE water images. Qualitative grading of the images was performed by three cardiologists with > 3, > 10, and > 14 years of experience in cardiac MR imaging (I.S., S.W., P.G.M, respectively), who were blinded to patient information and history. Detectability of fibrosis was performed by two of the experts separately (I.S., S.W.) with > 3 and > 10 years of experience in atrial cardiac MR imaging and atrial fibrillation. Both dNAV 3D LGE images and iNAV 3D LGE water images were imported to Osirix (Bernex, Switzerland) for assessment, so that brightness/contrast could be freely adjusted.
For each dataset, presence of fibrosis in the atrial wall was assessed with 3-class criteria: Absent with confidence, Present with confidence, or Inconclusive. Furthermore, all the images were graded in terms of image quality using a 4-point scale, with 1: Non-diagnostic, 2: Acceptable, 3: Good, 4: Full diagnostic. This assessment considered the following criteria: ability to visualize fibrosis, presence of inflow artefacts, respiratory motion induced artefacts and/or blurring, nulling point of the viable myocardium and quality of fat suppression. Image quality scores for each expert were compared with a paired Wilcoxon signed-rank test to assess statistical differences; p < 0.05 was considered statistically significant. Image quality scores provided by each expert reviewer are presented separately, and the average score for each method is reported as a summary statistic. Krippendorff’s alpha coefficient was computed to assess inter-rater reliability. In this study, agreement was interpreted as follows: alpha < 0.677 = inconclusive, 0.677–0.80 tentative inter-rater reliability, 0.80–1.00 high inter-rater reliability [31].
Time between administration of Gd-based contrast agent and start of each 3D LGE acquisition, and acquisition time were recorded for all scans. Acquisition time for both sequences were compared with a paired 2-tailed Student t test to assess statistical differences, with p < 0.05 considered statistically significant. All statistical analysis was performed using the software package SPSS (Version 26.0.0.1). Finally, in order to visually compare atrial fibrosis depiction for each patient, atrial shell images were generated for both the dNAV and iNAV 3D LGE images using the open source software CEMRG [32].
Results
The water/fat iNAV 3D LGE acquisition was successfully completed in all eighteen subjects with an average scan time of 4.5 ± 1.2 min, which was significantly shorter than the time required for conventional dNAV 3D LGE imaging (10.9 ± 3.9 min, p < 0.001). The heart rate of the subjects during the dNAV 3D LGE scan was 76.4 ± 14.2 bpm, while during the water/fat iNAV 3D LGE scan was 78.4 ± 14.5 bpm, with no statistically significant difference observed between both scans (p = 0.15).
Representative images obtained with both dNAV- and iNAV-based approaches for a patient without LGE findings are shown in Fig. 2, including an axial and coronal view. While a comparable depiction of the atrial wall is obtained with both techniques, an apparent inflow artefact can be observed in the dNAV-based image (red arrows), which is not present in the iNAV-based image. Figure 3 shows a similar visual comparison for a patient with atrial fibrosis findings (green arrows). Motion-induced artefacts can be observed in the dNAV-based image which are of similar intensity to the LGE areas and could potentially be misinterpreted as fibrosis, whereas the iNAV-based approach does not present evident remaining respiratory motion artefacts.
Figure 4 shows the image quality scores for each expert observer separately. For Expert 1 there was no statistically significant difference between image quality obtained with the dNAV and iNAV images (p = 1), while for the other two experts, iNAV images were significantly better than dNAV images (p = 0.0078 and p = 0.0088 respectively). Overall, average image quality for the iNAV images was 3.1 ± 1.0, while for dNAV images was 2.6 ± 1.0 (p = 0.0012). For both the assessment of iNAV images (α = 0.38) and dNAV images (α = 0.55), inter-rater reliability was found to be inconclusive (i.e., α below the cutoff criteria). For all reviewers, the presence of motion-induced artefacts was the most common reason for dNAV-based images not to be classified as full diagnostic, whilst motion blurring was the most common reason for image quality degradation with the water/fat iNAV-based approach.
LGE presence was separately assessed by two experts. Both of them deemed iNAV images as inconclusive less frequently than with dNAV images. Indeed, the first expert rated 4 dNAV and 2 iNAV images as inconclusive; while the second expert found 7 dNAV and 4 iNAV images inconclusive. For both dNAV and iNAV images inter-rater reliability was found to be inconclusive regarding fibrosis detection, with α = 0.30 for dNAV images and α = 0.31 for iNAV images. A summary of the assessment of presence of fibrosis in the images can be found in Table 2. An example case where dNAV-based images resulted in an inconclusive diagnosis is shown in Fig. 5, where respiratory-induced artefacts rendered the image non-diagnostic.
Figure 6 shows example water/fat iNAV-based atrial LGE images for three representative patients, including the atrial LGE image (water), the corresponding fat image and a fused image. The water/fat iNAV-based approach produces a fully co-registered complementary fat image that may be used for characterization of peri-atrial fat.
Despite iNAV-based images being acquired starting ~ 15 min after the conventional dNAV-based images (34.9 ± 5.9 min after administration of contrast agent), they resulted in overall good image quality and enabled good depiction of the atria and segmentation of atrial scar, as can be observed in the atrial shells in Fig. 7.
Discussion
In this study we have demonstrated the feasibility of a highly efficient framework for 3D water/fat LGE atrial wall imaging in about 5 min. Compared to conventional atrial LGE imaging, which uses diaphragmatic navigator gating for respiratory motion compensation, this approach relies on coronal iNAVs that enable 100% scan efficiency, resulting in a predictable scan time that only depends on the subjects’ heart rate and volumetric coverage required. In addition, the use of an undersampled variable density trajectory enabled further reduction of total scan time, without adversely affecting image quality.
Visual scoring showed that iNAV images achieve equal or superior image quality compared to dNAV images, moreover, the iNAV-based method achieved a significantly shorter scan time, with a 59% reduction compared to the conventional method. Furthermore, with the iNAV-based water/fat approach two potential sources of image artefacts were minimized: no inflow artefacts in the pulmonary vein were observed, and fat suppression was improved by the water/fat separation approach. While these two sources of artefacts have been previously addressed by techniques that include modifying the acquisition sequence to minimize inflow artefact [12, 15, 16] or the use of water/fat sequences [18], such techniques did not address the issue of unpredictable and prolonged scan times, which remains a challenge for the clinical adoption of atrial LGE imaging.
It is worth noting that for the conventional dNAV-based images, the main reason for images to be rated as other than full diagnostic was because of motion-induced artefacts. Depending on their location in the image, these artefacts can obscure and/or reduce the confidence in the detection of fibrosis in the atrial wall, as they appear as high intensity structures which could be misinterpreted as areas of enhancement. On the other hand, for the iNAV-based method, residual blurring was the most common cause for impaired image quality. As iNAV-based images were always acquired after the dNAV-based images, longer TIs were required due to contrast agent washout, which limited the selection of an optimal atrial diastolic window for data acquisition and may have resulted in motion artifacts. Furthermore, residual motion in the anterior–posterior (AP) direction is currently not corrected for in a beat-to-beat basis. Approaches such as virtual 3D iNAVs that exploit autofocus to estimate beat-to-beat AP motion could alleviate this problem in future studies [33]. Nevertheless, in most cases such blurring did not affect the diagnostic quality of the resulting images.
Overall, in the cohort recruited for this study conventional atrial LGE imaging resulted in 22.2/38.8% inconclusive scans (Reader 1/Reader 2 respectively), which is similar to values reported elsewhere in the literature. The iNAV-based approach resulted instead in 11.1/22.2% inconclusive scans (Reader 1/Reader 2 respectively), showing promise for improved diagnostic quality of atrial LGE imaging despite suboptimal timing after contrast agent injection.
A moderate threefold acceleration (with elliptical shutter) was used in this study resulting in a scan time of about 5 min for a spatial resolution matching the atrial imaging protocol used routinely at our institution. Other techniques available for accelerated atrial LGE imaging have used similar acceleration factors [19, 34, 35] to achieve scan times of approximately 6 min. However, they use more complex compressed-sensing and respiratory-resolved image reconstruction algorithms, that require up to 60 min of computation time. In contrast, our method can achieve good image quality with an inline reconstruction that requires only a few minutes.
While in this study a moderate acceleration and spatial resolution were used, further acceleration in combination with regularized image reconstruction approaches could enable increased spatial resolution and potentially an improved depiction of atrial fibrosis. Moreover, further acceleration could enable the extension of the iNAV-based water/fat imaging protocol to a phase-sensitive inversion recovery (PSIR) [36] approach for improved contrast between areas of atrial wall enhancement and blood pool.
This study has a number of limitations. Patients recruited for this study underwent a clinically referred cardiac MRI protocol including a conventional 3D LGE imaging protocol, acquired always ~ 20 min after contrast agent administration, in order to produce optimal image quality and to avoid any possible impairment to the clinical data. The clinical protocol was then followed by the iNAV 3D water/fat LGE and therefore the timing after contrast injection for this sequence was suboptimal. Indeed, data acquisition with the iNAV-based sequence started ~ 15 min after the acquisition of conventional dNAV-based images, resulting in intrinsic differences in the washout of contrast agent. Indeed, the average selected TI for the dNAV-based images was 253.3 ± 32.5 ms, while for the iNAV-based images was 276.1 ± 24.8 ms (significantly longer, p = 0.008). This difference reflects changes in the overall contrast of the image due to contrast washout, and it is especially noticeable in areas such as the aortic wall and mitral valve, which often appeared hyper-enhanced in the iNAV-based water LGE images. It is worth noting that such enhancement is consistent with findings in the literature and likely reflect increased extracellular volume in the aortic wall and the intrinsic fibrous composition of the valves [18]. Moreover, such difference does not seem to affect the ability to detect atrial scar, and previous reproducibility studies have shown good agreement in scar detection for scans starting 20 and 30 min after contrast agent administration [9]. Further studies considering randomization of the order in which images are acquired will be performed to fully characterize the performance of both approaches. Furthermore, while the detection of areas of enhancement was comparable between the conventional dNAV and the iNAV-based methods, there was no available gold-standard for assessing the true distribution of fibrosis/scar in the atria to be used as reference. Future studies that compare fibrosis/scar depiction between the proposed method and a gold-standard voltage map acquired using 3D electroanatomic mapping are warranted.
In conclusion, accelerated motion-compensated water/fat atrial 3D LGE imaging allows for the depiction of atrial fibrosis and scar with good image quality, comparable to conventional diaphragmatic navigator-gated protocols but with a 59% shorter scan time of about 5 min.
References
Vergara GR, Marrouche NF (2011) Tailored management of atrial fibrillation using a LGE-MRI based model: from the clinic to the electrophysiology laboratory. J Cardiovasc Electrophysiol 22:481–487
Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, Kholmovski E, Burgon N, Hu N, Mont L, Deneke T, Duytschaever M, Neumann T, Mansour M, Mahnkopf C, Herweg B, Daoud E, Wissner E, Bansmann P, Brachmann J (2014) Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation. JAMA 311:498
Chubb H, Karim R, Mukherjee R, Williams SE, Whitaker J, Harrison J, Niederer SA, Staab W, Gill J, Schaeffter T, Wright M, O’Neill M, Razavi R (2019) A comprehensive multi-index cardiac magnetic resonance-guided assessment of atrial fibrillation substrate prior to ablation: prediction of long-term outcomes. J Cardiovasc Electrophysiol 30:1894–1903
Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJE, Rao SN, DiBella EVR, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF (2009) Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 119:1758–1767
Cochet H, Mouries A, Nivet H, Sacher F, Derval N, Denis A, Merle M, Relan J, Hocini M, Haïssaguerre M, Laurent F, Montaudon M, Jaïs P (2015) Age, atrial fibrillation, and structural heart disease are the main determinants of left atrial fibrosis detected by delayed-enhanced magnetic resonance imaging in a general cardiology population. J Cardiovasc Electrophysiol 26:484–492
Khurram IM, Habibi M, Gucuk Ipek E, Chrispin J, Yang E, Fukumoto K, Dewire J, Spragg DD, Marine JE, Berger RD, Ashikaga H, Rickard J, Zhang Y, Zipunnikov V, Zimmerman SL, Calkins H, Nazarian S (2016) Left atrial LGE and arrhythmia recurrence following pulmonary vein isolation for paroxysmal and persistent AF. JACC Cardiovasc Imaging 9:142–148
Peters DC, Wylie JV, Hauser TH, Kissinger KV, Botnar RM, Essebag V, Josephson ME, Manning WJ (2007) Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience. Radiology 243:690–695
Bisbal F, Guiu E, Cabanas-Grandío P, Berruezo A, Prat-Gonzalez S, Vidal B, Garrido C, Andreu D, Fernandez-Armenta J, Tolosana JM, Arbelo E, de Caralt TM, Perea RJ, Brugada J, Mont L (2014) CMR-guided approach to localize and ablate gaps in repeat AF ablation procedure. JACC Cardiovasc Imaging 7:653–663
Chubb H, Karim R, Roujol S, Nuñez-Garcia M, Williams SE, Whitaker J, Harrison J, Butakoff C, Camara O, Chiribiri A, Schaeffter T, Wright M, O’Neill M, Razavi R (2018) The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study. J Cardiovasc Magn Reson 20:21
Quail M, Grunseich K, Baldassarre LA, Mojibian H, Marieb MA, Cornfeld D, Soufer A, Sinusas AJ, Peters DC (2019) Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 21:2
Siebermair J, Kholmovski EG, Marrouche N (2017) Assessment of left atrial fibrosis by late gadolinium enhancement magnetic resonance imaging. JACC Clin Electrophysiol 3:791–802
Peters DC, Shaw JL, Knowles BR, Moghari MH, Manning WJ (2013) Respiratory bellows-gated late gadolinium enhancement of the left atrium. J Magn Reson Imaging 38:1210–1214
Akkaya M, Higuchi K, Koopmann M, Burgon N, Erdogan E, Damal K, Kholmovski E, McGann C, Marrouche NF (2013) Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation. Europace 15:1725–1732
Sramko M, Peichl P, Wichterle D, Tintera J, Weichet J, Maxian R, Pasnisinova S, Kockova R, Kautzner J (2015) Clinical value of assessment of left atrial late gadolinium enhancement in patients undergoing ablation of atrial fibrillation. Int J Cardiol 179:351–357
Moghari MH, Peters DC, Smink J, Goepfert L, Kissinger KV, Goddu B, Hauser TH, Josephson ME, Manning WJ, Nezafat R (2011) Pulmonary vein inflow artifact reduction for free-breathing left atrium late gadolinium enhancement. Magn Reson Med 66:180–186
Keegan J, Drivas P, Firmin DN (2014) Navigator artifact reduction in three-dimensional late gadolinium enhancement imaging of the atria. Magn Reson Med 72:779–785
Santelli C, Nezafat R, Goddu B, Manning WJ, Smink J, Kozerke S, Peters DC (2011) Respiratory bellows revisited for motion compensation: preliminary experience for cardiovascular MR. Magn Reson Med 65:1097–1102
Shaw JL, Knowles BR, Goldfarb JW, Manning WJ, Peters DC (2014) Left atrial late gadolinium enhancement with water-fat separation: The importance of phase-encoding order. J Magn Reson Imaging 40:119–125
Gunasekaran S, Haji-Valizadeh H, Lee DC, Avery RJ, Wilson BD, Ibrahim M, Markl M, Passman RS, Kholmovski EG, Kim D (2020) Accelerated 3D left atrial late gadolinium enhancement in patients with atrial fibrillation at 15 T: technical development. Radiol Cardiothorac Imaging 2:e200134
Munoz C, Bustin A, Neji R, Kunze KP, Forman C, Schmidt M, Hajhosseiny R, Masci P, Zeilinger M, Wuest W, Botnar RM, Prieto C (2020) Motion-corrected 3D whole-heart water-fat high-resolution late gadolinium enhancement cardiovascular magnetic resonance imaging. J Cardiovasc Magn Reson 22:53
Zeilinger MG, Wiesmüller M, Forman C, Schmidt M, Munoz C, Piccini D, Kunze K-P, Neji R, Botnar RM, Prieto C, Uder M, May M, Wuest W (2020) 3D Dixon water-fat LGE imaging with image navigator and compressed sensing in cardiac MRI. Eur Radiol. https://doi.org/10.1007/s00330-020-07517-x
Henningsson M, Koken P, Stehning C, Razavi R, Prieto C, Botnar RM (2012) Whole-heart coronary MR angiography with 2D self-navigated image reconstruction. Magn Reson Med 67:437–445
Prieto C, Doneva M, Usman M, Henningsson M, Greil G, Schaeffter T, Botnar RM (2015) Highly efficient respiratory motion compensated free-breathing coronary MRA using golden-step Cartesian acquisition. J Magn Reson Imaging 41:738–746
Bustin A, Ginami G, Cruz G, Correia T, Ismail TF, Rashid I, Neji R, Botnar RM, Prieto C (2019) Five-minute whole-heart coronary MRA with sub-millimeter isotropic resolution, 100% respiratory scan efficiency, and 3D-PROST reconstruction. Magn Reson Med 81:102–115
Kunze KP, Piccini D, Forman C, Pang J, Schmidt M, Prieto C, Botnar R, Neji R (2019) 3D whole-heart imaging with orientation-independent 2D image navigators. Soc Magn Reson Angiogr 31st Annu Int Conf. p 25
Cruz G, Atkinson D, Henningsson M, Botnar RM, Prieto C (2017) Highly efficient nonrigid motion-corrected 3D whole-heart coronary vessel wall imaging. Magn Reson Med 77:1894–1908
Munoz C, Cruz G, Neji R, Botnar RM, Prieto C (2019) Motion corrected water/fat whole-heart coronary MR angiography with 100% respiratory efficiency. Magn Reson Med 82:732–742
Chefd’hotel C, Hermosillo G, Faugeras O (2002) Flows of diffeomorphisms for multimodal image registration, Proc IEEE Int Symp Biomed Imaging. IEEE, pp 753–756
Batchelor PG, Atkinson D, Irarrazaval P, Hill DLG, Hajnal J, Larkman D (2005) Matrix description of general motion correction applied to multishot images. Magn Reson Med 54:1273–1280
Ma J (2004) Breath-hold water and fat imaging using a dual-echo two-point dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med 52:415–419
Krippendorff K (2018) Content analysis: an introduction to its methodology. SAGE Publications
Sim I, Razeghi O, Karim R, Chubb H, Whitaker J, O’Neill L, Mukherjee RK, Roney CH, Razavi R, Wright M, O’Neill M, Niederer S, Williams SE (2019) Reproducibility of atrial fibrosis assessment using CMR imaging and an open source platform. JACC Cardiovasc Imaging 12:2076–2077
Psenicny A, Cruz G, Munoz C, Hajhosseiny R, Kuestner T, Kunze KP, Neji R, Botnar RM, Prieto C (2021) Whole-heart CMRA non-rigid motion compensation with autofocus virtual 3D iNAV. Proc ISMRM 29th Annu Meet Exhib. ISMRM, p 0009
Akçakaya M, Rayatzadeh H, Basha TA, Hong SN, Chan RH, Kissinger KV, Hauser TH, Josephson ME, Manning WJ, Nezafat R (2012) Accelerated late gadolinium enhancement cardiac mr imaging with isotropic spatial resolution using compressed sensing: initial experience. Radiology 264:691–699
Basha TA, Akçakaya M, Liew C, Tsao CW, Delling FN, Addae G, Ngo L, Manning WJ, Nezafat R (2017) Clinical performance of high-resolution late gadolinium enhancement imaging with compressed sensing. J Magn Reson Imaging 46:1829–1838
Kellman P, Arai AE, McVeigh ER, Aletras AH (2002) Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 47:372–383
Acknowledgements
This research was funded in whole, or in part, by the Wellcome Trust through the grant NS/A000049/1. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.
Funding
This work was supported by the following grants: (1) EPSRC EP/P032311/1, EP/P007619/1, EP/P001009/1; (2) BHF programme grant RG/20/1/34802 and (3) Wellcome/EPSRC Centre for Medical Engineering (WT 203148/Z/16/Z). This research was supported by the National Institute for Health Research (NIHR) Cardiovascular Health Technology Cooperative (HTC) and the Biomedical Research Centre based at Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Data acquisition was performed by CM and IS. Analysis and interpretation of data was performed by CM, IS, RN, KPK, PGM, MS, MON, SW, RMB, CP. The first draft of the manuscript was written by CM, IS and CP, and critical revision was performed by all authors. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of interest
RN, KPK, MS are employees of Siemens Healthcare. All the other Authors declare that they do not have competing interests.
Ethics approval
All procedures performed in this study were in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study was approved by the National Research Ethics Service (REC 15/NS/0030).
Informed consent
Written informed consent was obtained from each participant according to institutional guidelines.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Munoz, C., Sim, I., Neji, R. et al. Evaluation of accelerated motion-compensated 3d water/fat late gadolinium enhanced MR for atrial wall imaging. Magn Reson Mater Phy 34, 877–887 (2021). https://doi.org/10.1007/s10334-021-00935-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10334-021-00935-y